Literature DB >> 20331949

Venous thromboembolism: a public health concern.

Michele G Beckman1, W Craig Hooper, Sara E Critchley, Thomas L Ortel.   

Abstract

Venous thromboembolism (VTE), defined as deep vein thrombosis, pulmonary embolism, or both, affects an estimated 300,000-600,000 individuals in the U.S. each year, causing considerable morbidity and mortality. It is a disorder that can occur in all races and ethnicities, all age groups, and both genders. With many of the known risk factors-advanced age, immobility, surgery, obesity-increasing in society, VTE is an important and growing public health problem. Recently, a marked increase has occurred in federal and national efforts to raise awareness and acknowledge the need for VTE prevention. Yet, many basic public health functions-surveillance, research, and awareness-are still needed. Learning and understanding more about the burden and causes of VTE, and raising awareness among the public and healthcare providers through a comprehensive public health approach, has enormous potential to prevent and reduce death and morbidity from deep vein thrombosis and pulmonary embolism throughout the U.S. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20331949     DOI: 10.1016/j.amepre.2009.12.017

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  222 in total

1.  Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study.

Authors:  Antonio P Arenas de Larriva; Alvaro Alonso; Faye L Norby; Nicholas S Roetker; Aaron R Folsom
Journal:  J Thromb Haemost       Date:  2019-03-18       Impact factor: 5.824

2.  Early chemoprophylaxis is associated with decreased venous thromboembolism risk without concomitant increase in intraspinal hematoma expansion after traumatic spinal cord injury.

Authors:  Ronald Chang; Michelle H Scerbo; Karl M Schmitt; Sasha D Adams; Timothy J Choi; Charles E Wade; John B Holcomb
Journal:  J Trauma Acute Care Surg       Date:  2017-12       Impact factor: 3.313

Review 3.  Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

Authors:  Jonathan Stone; Patrick Hangge; Hassan Albadawi; Alex Wallace; Fadi Shamoun; M Grace Knuttien; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 4.  Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.

Authors:  Drew Fleck; Hassan Albadawi; Fadi Shamoun; Grace Knuttinen; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

5.  Acute pulmonary embolism in patients with obstructive sleep apnea: frequency, hospital outcomes, and recurrence.

Authors:  Zeynep Idil Seckin; Haytham Helmi; Timothy J Weister; Augustine Lee; Emir Festic
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

Review 6.  Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism.

Authors:  Celeste B Burness; Caroline M Perry
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

7.  Assessment of Direct Oral Anticoagulant Prescribing and Monitoring Pre- and Post-Implementation of a Pharmacy Protocol at a Community Teaching Hospital.

Authors:  Christina Miele; Mary Taylor; Aditi Shah
Journal:  Hosp Pharm       Date:  2017-03

8.  High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

Authors:  Amanda B Payne; Connie H Miller; W Craig Hooper; Cathy Lally; Harland D Austin
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

9.  Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients.

Authors:  Lara Yoon; Grace Clarke Hillyer; Ling Chen; Jim C Hu; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Cancer Invest       Date:  2016-09-13       Impact factor: 2.176

10.  Massive pulmonary embolism leading to cardiac arrest: one pathology, two different ECMO modes to assist patients.

Authors:  Raphaël Giraud; Carlo Banfi; Nils Siegenthaler; Karim Bendjelid
Journal:  J Clin Monit Comput       Date:  2015-10-26       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.